SFM
Sphera Funds Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77M | Buy |
+174,900
| New | +$3.77M | 0.89% | 36 |
|
|
2025
Q1 | – | Sell |
-288,539
| Closed | -$5.29M | – | 113 |
|
|
2024
Q4 | $5.29M | Buy |
288,539
+36,000
| +14% | +$661K | 0.96% | 39 |
|
|
2024
Q3 | $3.88M | Sell |
252,539
-75,000
| -23% | -$1.15M | 0.62% | 50 |
|
|
2024
Q2 | $5.32M | Buy |
327,539
+202,539
| +162% | +$3.29M | 0.73% | 42 |
|
|
2024
Q1 | $2.31M | Buy |
+125,000
| New | +$2.31M | 0.32% | 68 |
|
|
2020
Q2 | – | Sell |
-157,000
| Closed | -$6.63M | – | 81 |
|
|
2020
Q1 | $6.63M | Sell |
157,000
-200,000
| -56% | -$8.45M | 0.83% | 25 |
|
|
2019
Q4 | $15.3M | Buy |
357,000
+267,000
| +297% | +$11.4M | 1.26% | 11 |
|
|
2019
Q3 | $3.24M | Buy |
+90,000
| New | +$3.24M | 0.5% | 54 |
|
|
2018
Q1 | – | Sell |
-170,000
| Closed | -$5.12M | – | 105 |
|
|
2017
Q4 | $5.12M | Buy |
+170,000
| New | +$5.12M | 0.6% | 37 |
|
|
2016
Q4 | – | Sell |
-125,000
| Closed | -$3.98M | – | 100 |
|
|
2016
Q3 | $3.98M | Buy |
+125,000
| New | +$3.98M | 0.65% | 34 |
|
|
2016
Q2 | – | Sell |
-150,000
| Closed | -$4.19M | – | 84 |
|
|
2016
Q1 | $4.19M | Buy |
150,000
+50,000
| +50% | +$1.4M | 0.91% | 16 |
|
|
2015
Q4 | $3.57M | Buy |
+100,000
| New | +$3.57M | 0.52% | 35 |
|
|
2014
Q1 | – | Sell |
-60,000
| Closed | -$1.5M | – | 101 |
|
|
2013
Q4 | $1.5M | Buy |
+60,000
| New | +$1.5M | 0.42% | 53 |
|